The nation of Zimbabwe has turned down a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) over five years over the United States' demand for sensitive biological samples.
This move came to light following a internal memorandum from December was disclosed, which showed President Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesperson has since clarified that the US was requesting health data for scientific study and commercial purposes but was not willing to guarantee the resulting advantages from future medical innovations.
"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged further negotiations to find a deal suitable to both sides so the nation's vital HIV programme can be sustained.
Broader Context
Zimbabwe's decision comes after a similar case in Kenya, where a high court halted a related health funding agreement after legal challenges were filed about the security of Kenyans' health data.
After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government deals to enhance transparency and responsibility.
As per statements, 16 nations in Africa have to date agreed to similar health pacts, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
The funds for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment via American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information for a long time, without any corresponding guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"Put simply, our nation would provide the basic resources for medical research without any certainty that the end products would be available to our citizens if a future disease outbreak arise."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were upending frameworks previously established via the global organization.
Mangwana cited its Pandemic Benefit-Sharing system created to manage future pandemics.
"This framework is intended to guarantee that when a country provides its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to develop them."
These objections over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to further discussions with our US partners on how future collaboration could be designed in a manner that respects the sovereignty and interests of both nations."
Medical Community Response
A leading public health body said it understood the government's concerns, but urged that negotiations need to persist considering much of the country's Aids initiatives were funded by external financing.
"In cases where technical issues exist, such as those relating to data governance or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," the group said.
The halted deal emphasises the ongoing challenges between accepting vital foreign assistance and protecting a country's data in an ever more data-driven world.